Bioequivalence Study of Generic Tretinoin 0.1% Microsphere Gel, 0.1% Retin-A Micro® and Placebo

NCT01135069 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
480
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Spear Pharmaceuticals